Premalata Pati, PhD, PostDoc in Biological Sciences, Medical Text Analysis with Machine Learning
https://pharmaceuticalintelligence.com/contributors-biographies/postdoctorants-computer-science-pharmaceutical-sciences-biological-sciences/premalata-pati-phd-postdoc-in-pharmaceutical-sciences-medical-text-analysis-with-machine-learning/
2. Progress on Text Analysis
Sl No. Date Article Name Article URL 1 July 6, 2021 Yet another Success Story: Machine Learning to predict immunotherapy response https://pharmaceuticalintelligence.com/2021/07/06/yet-another-success-story-machine-learning-to-predict-immunotherapy-response/ 2 July 2, 2021 The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccine https://pharmaceuticalintelligence.com/2021/07/02/the-nih-funded-adjuvant-improves-the-efficacy-of-indias-covid-19-vaccine/ 3 June 20, 2021 Non-toxic antiviral nanoparticles with a broad spectrum of virus inhibition https://pharmaceuticalintelligence.com/2021/06/20/non-toxic-antiviral-nanoparticles-with-a-broad-spectrum-of-virus-inhibition/ 4 June 10, 2021 Despite heated discussion over whether it works, the FDA has approved Aduhelm, bringing a new ray of hope to the Alzheimer’s patients. https://pharmaceuticalintelligence.com/2021/06/10/despite-heated-discussion-over-whether-it-works-the-fda-has-approved-aduhelm-bringing-a-new-ray-of-hope-to-the-alzheimers-patients/ 5 May 27, 2021 Renal tumor macrophages linked to recurrence are identified using single-cell protein activity analysis https://pharmaceuticalintelligence.com/2021/05/27/renal-tumor-macrophages-linked-to-recurrence-are-identified-using-single-cell-protein-activity-analysis/ 6 May 4, 2021 Machine Learning (ML) in cancer prognosis prediction helps the researcher to identify multiple known as well as candidate cancer diver genes https://pharmaceuticalintelligence.com/2021/05/04/machine-learning-ml-in-cancer-prognosis-prediction-helps-the-researcher-to-identify-multiple-known-as-well-as-candidate-cancer-diver-genes/ 7 April 10, 2021 Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure. https://pharmaceuticalintelligence.com/2021/04/10/cryo-em-disclosed-how-the-d614g-mutation-changes-sars-cov-2-spike-protein-structure/ 8 March 22, 2021 Gene Therapy could be a Boon to Alzheimer’s disease (AD): A first-in-human clinical trial proposed https://pharmaceuticalintelligence.com/2021/03/22/gene-therapy-could-be-a-boon-to-alzheimers-disease-ad-a-first-in-human-clinical-trial-proposed / 9 February 20, 2021 Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysis https://pharmaceuticalintelligence.com/2021/02/20/inhibitory-cd161-receptor-identified-in-glioma-infiltra ting-t-cells-by-single-cell-analysis-2/
26 June 2021
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 12 Completion
Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT
URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-12
WORD CLOUDs Uploaded in Articles of Chapter 12
Article 12.1- https://pharmaceuticalintelligence.com/2013/05/15/dna-nanotechnology/
Article 12.2- https://pharmaceuticalintelligence.com/2013/01/09/nanotechnology-personalized-medicine-and-dna-sequencing/
Article 12.3- https://pharmaceuticalintelligence.com/2012/12/09/naotech-therapy-for-breast-cancer/
Article 12.4- https://pharmaceuticalintelligence.com/2013/02/07/prostate-cancer-and-nanotecnology/
Article 12.5- Missing
Article 12.6- https://pharmaceuticalintelligence.com/2012/11/23/nanotechnology-tackles-brain-cancer/
Article 12.7- https://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 11 Completion
Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT
URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-11
WORD CLOUDs Uploaded in Articles of Chapter 11
Article 11.1.1- https://pharmaceuticalintelligence.com/2012/08/27/the-incentive-for-imaging-based-cancer-patient-management/
Article 11.1.2- https://pharmaceuticalintelligence.com/2013/03/10/imaging-biomarkers-is-imaging-based-tissue-characterization/
Article 11.2.1- https://pharmaceuticalintelligence.com/2013/04/10/2013-year-of-the-ultrasound/
Article 11.2.2- https://pharmaceuticalintelligence.com/2012/09/10/imaging-seeing-or-imagining-part-1/
Article 11.2.3- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/
Article 11.2.4- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/
Article 11.2.5- https://pharmaceuticalintelligence.com/2013/01/28/state-of-the-art-in-oncologic-imaging-of-prostate/
Article 11.2.6- https://pharmaceuticalintelligence.com/2013/05/05/from-aua2013-histoscanning-aided-template-biopsies-for-patients-with-previous-negative-trus-biopsies/
Article 11.2.7- https://pharmaceuticalintelligence.com/2013/02/15/on-the-road-to-improve-prostate-biopsy/
Article 11.2.8- https://pharmaceuticalintelligence.com/2013/06/06/ultrasound-imaging-as-an-instrument-for-measuring-tissue-elasticity-shear-wave-elastography-vs-strain-imaging/
Article 11.2.9- https://pharmaceuticalintelligence.com/2012/11/19/what-could-transform-an-underdog-into-a-winner/
Article 11.2.10- https://pharmaceuticalintelligence.com/2013/04/28/ultrasound-based-screening-for-ovarian-cancer/
Article 11.2.11- https://pharmaceuticalintelligence.com/2013/03/22/imaging-guided-cancer-therapy-a-discipline-in-need-of-guidance/
Article 11.3.1- https://pharmaceuticalintelligence.com/2012/10/09/introducing-smart-imaging-into-radiologists-daily-practice/
Article 11.3.2- https://pharmaceuticalintelligence.com/2012/09/29/imaging-seeing-or-imagining-part-2/
Article 11.3.3- https://pharmaceuticalintelligence.com/2012/09/29/imaging-guided-biopsies-is-there-a-preferred-strategy-to-choose/
Article 11.3.4- https://pharmaceuticalintelligence.com/2012/12/16/new-clinical-results-supports-imaging-guidance-for-targeted-prostate-biopsy/
Article 11.3.5- https://pharmaceuticalintelligence.com/2013/01/03/whole-body-imaging-as-cancer-screening-tool-answering-an-unmet-clinical-need/
Article 11.3.6- https://pharmaceuticalintelligence.com/2013/02/03/state-of-the-art-in-oncologic-imaging-of-lymphoma/
Article 11.3.7- https://pharmaceuticalintelligence.com/2012/12/09/a-corner-in-the-medical-imagings-eco-system/
Article 11.4.1- https://pharmaceuticalintelligence.com/2013/05/18/causes-and-imaging-features-of-false-positives-and-false-negatives-on-18f-petct-in-oncologic-imaging/
Article 11.4.2- https://pharmaceuticalintelligence.com/2013/04/15/minimally-invasive-image-guided-therapy-for-inoperable-hepatocellular-carcinoma/
Article 11.4.3- https://pharmaceuticalintelligence.com/2013/01/14/improving-mammography-based-imaging-for-better-treatment-planning/
Article 11.4.4- https://pharmaceuticalintelligence.com/2012/11/04/closing-the-mammography-gap/
Article 11.4.5- https://pharmaceuticalintelligence.com/2013/01/23/state-of-the-art-in-oncologic-imaging-of-lungs/
Article 11.4.6- https://pharmaceuticalintelligence.com/2013/01/19/ovarian-cancer-and-fluorescence-guided-surgery-a-report/
Article 11.5.1- https://pharmaceuticalintelligence.com/2012/12/24/optical-coherent-tomography-emerging-technology-in-cancer-patient-management/
Article 11.5.2- https://pharmaceuticalintelligence.com/2013/01/09/new-imaging-device-bears-a-promise-for-better-quality-control-of-breast-cancer-lumpectomies-considering-the-cost-impact/
Article 11.5.3- https://pharmaceuticalintelligence.com/2013/03/03/virtual-biopsy-is-it-possible/
Article 11.5.4- https://pharmaceuticalintelligence.com/2013/02/22/new-envelopment-in-measuring-mechanical-properties-of-tissue/
18 June 2021
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 10 Completion
Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT
URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-10
WORD CLOUDs Uploaded in Articles of Chapter 10
Article 10.1- https://pharmaceuticalintelligence.com/2013/04/21/mesothelin-an-early-detection-biomarker-for-cancer-by-jack-andraka/
Article 10.2- https://pharmaceuticalintelligence.com/2012/12/25/stanniocalcin-a-cancer-biomarker/
Article 10.3- https://pharmaceuticalintelligence.com/2012/12/24/breast-cancer-genomic-profiling-to-predict-survival-combination-of-histopathology-and-gene-expression-analysis/
Article 10.4- https://pharmaceuticalintelligence.com/2012/10/24/biomarker-tool-development-for-early-diagnosis-of-pancreatic-cancer-van-andel-institute-and-emory-university/
Article 10.5- https://pharmaceuticalintelligence.com/2012/05/17/early-biomarker-for-pancreatic-cancer-identified/
Article 10.6- https://pharmaceuticalintelligence.com/2012/09/18/head-and-neck-cancer-studies-suggest-alternative-markers-more-prognostically-useful-than-hpv-dna-testing/
Article 10.7- https://pharmaceuticalintelligence.com/2013/05/29/opens-exome-service-for-rare-diseases-advanced-cancer-mayo-clinics-oncospire/
Article 10.8- https://pharmaceuticalintelligence.com/2013/05/23/in-search-of-clarity-on-prostate-cancer-screening-post-surgical-followup-and-prediction-of-long-term-remission/
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 9 Completion
Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT
URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-9
WORD CLOUDs Uploaded in Articles of Chapter 9
Article 9.1- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/
Article 9.2- https://pharmaceuticalintelligence.com/2013/05/20/testing-for-multiple-genetic-mutations-via-ngs-for-patients-very-strong-family-history-of-breast-ovarian-cancer-diagnosed-at-young-ages-negative-on-brca-test/
Article 9.3- https://pharmaceuticalintelligence.com/2013/05/16/a-blood-test-to-identify-aggressive-prostate-cancer-a-discovery-sri-international-menlo-park-ca/
Article 9.4- https://pharmaceuticalintelligence.com/2013/06/13/combining-nanotube-technology-and-genetically-engineered-antibodies-to-detect-prostate-cancer-biomarkers/
Article 9.5- https://pharmaceuticalintelligence.com/2012/09/23/warning-signs-may-lead-to-better-early-detection-of-ovarian-cancer/
Article 9.6- https://pharmaceuticalintelligence.com/2012/10/16/knowing-the-tumors-size-and-location-could-we-target-treatment-to-the-roi-by-applying-imaging-guided-intervention/
13 June 2021
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 8 Completion Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT
URL:
https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-8
WORD CLOUDs Uploaded in Articles of Chapter 8
Article 8.1- https://pharmaceuticalintelligence.com/2013/05/21/prostate-cancer-molecular-diagnostic-market-the-players-are-sri-intl-genomic-health-wcleveland-clinic-myriad-genetics-wucsf-genomedx-and-biotheranostics/
Article 8.2- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/
Article 8.3- https://pharmaceuticalintelligence.com/2012/07/31/prostate-cancers-plunged-after-uspstf-guidance-will-it-happen-again/
Article 8.4- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/
Article 8.5- https://pharmaceuticalintelligence.com/2012/12/01/diagnosing-lung-cancer-in-exhaled-breath-using-gold-nanoparticles/
11 June 2021
LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 7 Completion
Dropbox – Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT
URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-7
WORD CLOUDs Uploaded in Articles of Chapter 7
Article 7.1.1- https://pharmaceuticalintelligence.com/2013/01/12/harnessing-personalized-medicine-for-cancer-management-prospects-of-prevention-and-cure-opinions-of-cancer-scientific-leaders-httppharmaceuticalintelligence-com/
Article 7.1.2- https://pharmaceuticalintelligence.com/2012/11/20/personalized-medicine-based-cure-for-cancer-might-not-be-far-away/
Article 7.1.3- https://pharmaceuticalintelligence.com/2013/01/07/personalized-medicine-gearing-up-to-tackle-cancer/
Article 7.1.4- https://pharmaceuticalintelligence.com/2013/03/25/tel-aviv-sourasky-medical-center-cancer-prevention-center-excellent-example-for-adopting-prevention-of-cancer-as-a-mean-of-fighting-it/
Article 7.1.5- https://pharmaceuticalintelligence.com/2013/01/10/inspiration-from-dr-maureen-cronins-achievements-in-applying-genomic-sequencing-to-cancer-diagnostics/
Article 7.1.6- https://pharmaceuticalintelligence.com/2012/12/01/personalized-medicine-cancer-cell-biology-and-minimally-invasive-surgery-mis/
Article 7.2.1- https://pharmaceuticalintelligence.com/2012/10/29/cancer-genomics-leading-the-way-by-cancer-genomics-program-at-uc-santa-cruz/
Article 7.2.2- https://pharmaceuticalintelligence.com/2013/04/23/whole-exome-somatic-mutations-analysis-of-malignant-melanoma-contributes-to-the-development-of-personalized-cancer-therapy-for-this-disease/
Article 7.2.3- https://pharmaceuticalintelligence.com/2013/04/22/genotype-based-analysis-for-cancer-therapy-using-large-scale-data-modeling-nayoung-kim-phdc/
Article 7.2.4- https://pharmaceuticalintelligence.com/2013/04/21/cancer-genomic-precision-therapy-digitized-tumors-genome-wgsa-compared-with-genome-native-germ-line-flash-frozen-specimen-and-formalin-fixed-paraffin-embedded-specimen-needed/
Article 7.2.5- https://pharmaceuticalintelligence.com/2013/01/13/leaders-in-genome-sequencing-of-genetic-mutations-for-therapeutic-drug-selection-in-cancer-personalized-treatment-part-2/
Article 7.2.6- https://pharmaceuticalintelligence.com/2013/03/27/ethical-concerns-in-personalized-medicine-brca12-testing-in-minors-and-communication-of-breast-cancer-risk/
Article 7.3.1- https://pharmaceuticalintelligence.com/2013/05/09/the-development-of-sirna-based-therapies-for-cancer/
Article 7.3.2- https://pharmaceuticalintelligence.com/2012/10/26/mrna-interference-with-cancer-expression/
Article 7.3.3- https://pharmaceuticalintelligence.com/2013/05/07/cd47-target-therapy-for-cancer/
Article 7.3.4- https://pharmaceuticalintelligence.com/2013/04/06/targeting-mitochondrial-bound-hexokinase-for-cancer-therapy/
Article 7.3.5- https://pharmaceuticalintelligence.com/2012/11/14/gsk-for-personalized-medicine-using-cancer-drugs-needs-alacris-systems-biology-model-to-determine-the-in-silico-effect-of-the-inhibitor-in-its-virtual-clinical-trial/
Article 7.3.6- https://pharmaceuticalintelligence.com/2012/10/16/personalized-pancreatic-cancer-treatment-option/
Article 7.3.7- https://pharmaceuticalintelligence.com/2013/05/30/new-scheme-to-routinely-test-patients-for-inherited-cancer-genes/
Article 7.3.8- https://pharmaceuticalintelligence.com/2013/11/01/targeting-untargetable-proto-oncogenes/
Article 7.3.9- https://pharmaceuticalintelligence.com/2014/03/05/the-future-of-translational-medicine-with-smart-diagnostics-and-therapies-pharmacogenomics/#comment-54338
Article 7.4.1- https://pharmaceuticalintelligence.com/2013/05/25/personalized-medicine-and-colon-cancer/
Article 7.4.2- https://pharmaceuticalintelligence.com/2012/09/10/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/
Article 7.4.3- https://pharmaceuticalintelligence.com/2012/09/10/targeted-tumor-penetrating-sirna-nanocomplexes-for-credentialing-the-ovarian-cancer-oncogene-id4/
Article 7.4.4- https://pharmaceuticalintelligence.com/2012/06/19/cancer-and-bone-low-magnitude-vibrations-help-mitigate-bone-loss-5-2/
Article 7.4.5- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/
2012pharmaceutical
sjwilliamspa